The First and Most Advanced Proton Therapy System for Cancer Treatment in Tampa Bay
The Proteus®ONE, a new generation, compact, single-room proton therapy system developed by IBA, offers unparalleled precision in cancer treatment.
Moffitt Cancer Center is bringing the most advanced proton therapy system to the greater Tampa Bay area: The Proteus®ONE.
Proton therapy is one of the most advanced cancer treatment technologies available. While conventional radiation uses photons, proton therapy uses protons, or positively charged atomic particles. Protons can be precisely controlled to release much of their energy directly into the tumor, thereby reducing damage to nearby healthy tissue.
This transformative technology positions Moffitt at the forefront of cancer care and offers patients access to highly effective, minimally invasive treatments that produce better outcomes.
Proton Precision. Human Expertise.
Opening in summer 2026, Moffitt's Richard M. Schulze Family Foundation Proton Center​ and the Proteus®ONE system will solidify Moffitt’s Speros campus as a premier health care destination and emerging global hub for research and innovation.
Schedule a Proton Therapy Consultation
The Most Reliable, Highest-Quality Proton Beam
- IBA Proteus®ONE produces a pure, stable beam that ensures consistent dose delivery with every treatment session
- Sharpest pencil beam scanning available, minimizing the amount of potentially harmful side effects
- Sophisticated design combines advanced gantry rotation and robotic positioning technology, allowing clinicians to customize treatment and be more precise
- Moffitt is the first in the Tampa Bay area to receive this advanced system

Proteus®ONE Proton Therapy System Highlights
- Most advanced proton therapy system in the world
- Sharpest pencil beam scanning available, minimizing the amount of potentially harmful secondary radiation
- Sophisticated design combines advanced gantry rotation and robotic positioning technology, allowing clinicians to customize treatment plans with the highest degree of accuracy
- Moffitt is the first in the Tampa Bay area to receive this advanced system
- Moffitt Proton Center opening in summer 2026
An Expert Team Ready to Serve You
Feel confident choosing Moffitt for your cancer care. Our experts focus exclusively on the evaluation, diagnosis, and treatment of cancer and have an unparalleled level of experience and expertise, which leads to better outcomes and improved quality of life for our patients.
Plus, 99% of Moffitt's providers have received a rating of 4.5 stars or higher from past patients. You can read all the patient comments on their biography pages.
-
Meet Our Proton Therapy Team
Program
Radiation Oncology
Title
Vice Chair, Department of Radiation Oncology
Specialty
Radiation Oncology
4.9 (47)
-
Meet Our Speros Team
Program
Radiation Oncology
Specialty
Radiation Oncology
Cancer Focus
Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer, Proton Therapy, Sarcoma, Testicular Cancer
4.9 (267)
Program
Genitourinary Oncology
Specialty
Urology
Cancer Focus
Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer
Program
MMG Ambulatory HemOnc
Specialty
Hematology/Oncology
Cancer Focus
Bladder Cancer, Colon Cancer, Colorectal Cancer, Kidney (Renal Cell) Cancer, Lung Cancer, Pancreatic Cancer, Prostate Cancer, Rectal Cancer
Program
Radiation Oncology
Specialty
Radiation Oncology
Cancer Focus
Brain Cancer, Glioblastoma, Meningioma, Proton Therapy, Spinal Tumor, Throat Cancer, Thyroid Cancer, Tongue Cancer
4.9 (141)
Program
Genitourinary Oncology
Specialty
Urology
Cancer Focus
Bladder Cancer, Kidney (Renal Cell) Cancer, Prostate Cancer
4.8 (270)
Program
Radiation Oncology
Title
Vice Chair, Department of Radiation Oncology
Specialty
Radiation Oncology
Cancer Focus
Endometrial (Uterine) Cancer, Ovarian Cancer, Proton Therapy, Rectal Cancer, Vaginal Cancer, Vulvar Cancer
4.9 (47)
Program
MMG Ambulatory HemOnc
Specialty
Hematology/Oncology
Cancer Focus
Anal Cancer, Appendiceal (Appendix) Cancer, Benign Hematology, Bladder Cancer, Breast Cancer, Colon Cancer, Colorectal Cancer, Ductal Carcinoma In Situ, Esophageal Cancer, Gallbladder Cancer, Hodgkin Lymphoma, Leukemia, Lung Cancer, Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Rectal Cancer
4.8 (150)
Program
MMG Ambulatory HemOnc
Specialty
Medical Oncology
Cancer Focus
Lung Cancer, Mesothelioma, Neuroendocrine Tumor, Pancoast Tumor, Thymoma
5 (233)
Program
Radiation Oncology
Specialty
Radiation Oncology
Cancer Focus
Brain Cancer, Glioblastoma, Meningioma, Pituitary Neoplasm, Proton Therapy, Spinal Tumor
Specialty
Medical Oncology
Cancer Focus
Anal Cancer, Appendiceal (Appendix) Cancer, Bladder Cancer, Breast Cancer, Colon Cancer, Colorectal Cancer, Esophageal Cancer, Hodgkin Lymphoma, Invasive Ductal Carcinoma, Kidney (Renal Cell) Cancer, Leukemia, Lung Cancer, Melanoma, Multiple Myeloma-Plasma Cell Disorders, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Rectal Cancer, Small Intestine Cancer, Stomach (Gastric) Cancer, Triple Negative Breast Cancer
4.9 (113)
Defining the Future of Cancer Treatment
Combined with an expert team of the world's top clinicians, therapists and physicists, proton therapy gives Moffitt patients access to highly effective treatments. With better results and the ability to treat complex or difficult-to-reach tumors, especially those located near critical organs, IBA's Proteus®ONE will help Moffitt patients return to their lives faster and with fewer treatment side effects.
Cancers commonly treated with proton therapy:
- Brain Cancer
- Breast Cancer
- Colorectal Cancer
- Esophageal Cancer
- Head and Neck Cancers
- Liver Cancer
- Lung Cancer
- Pancreatic Cancer
- Pituitary Gland Tumors
- Prostate Cancer
- Sarcoma